Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients.
Jing SunTianyu ZhaoDi ZhaoXin QiXuanwen BaoRun ShiChuan SuPublished in: Therapeutic advances in medical oncology (2020)
Our study might contribute to the optimization of risk stratification for survival and personalized management of early-stage LUAD.